Several conditions associated with reduced gastric acid secretion confer an altered risk of developing a gastric malignancy. Helicobacter pylori-induced atrophic gastritis predisposes to gastric adenocarcinoma. autoimmune atrophic gastritis is a precursor of type I gastric neuroendocrine tumours. whereas proton pump inhibitor (PPI) use does not affect stomach cancer risk. https://www.divivoyance.com/product-category/chiller/